Rieger Jayson's Form 4 filing
Verrica Pharmaceuticals Inc. (VRCA) · filed Nov 26, 2024
- Accession no.
- 0001415889-24-027711
- Filed
- Nov 26, 2024
- Trade date
- Nov 22-26, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rieger JaysonCIK 0002043558 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | Common Stock | PPurchaseAcquired | +280,898 | – | – | 832,826 | Direct | |
| Nov 26, 2024 | Common Stock | GGiftAcquired | +50,000 | $0.00 | $0 | 882,826 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | Common Stock | PPurchaseAcquired | +140,449 | – | – | 140,449 | Direct | |
| Nov 22, 2024 | Common Stock | PPurchaseAcquired | +140,449 | – | – | 140,449 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.